We welcome your feedback on this report and the calls for action, recommendations and ideas outlined within it. 

The poll should only take a few minutes to complete and we would be extremely grateful for your participation.

All responses and data will be treated anonymously and used in aggregate form to portray trends. Data trends will be shared with the IHM and Merck.

Question Title

* 1. Key stakeholders in primary and secondary care should be brought together to construct a “collaborative commissioning” framework for MS

Question Title

* 2. To support the drive for further equity in access and reduce the capacity pressures on MS services, the commissioning of DMDs, and the service that wraps around them, should be commissioned together

Question Title

* 3. The DMD drug budget should remain nationally commissioned by NHS England to assure equity of access

Question Title

* 4. Best practice shared care arrangements between hub and spoke models are needed, that allow for greater local flexibility in the set-up of specialist spokes e.g. Blueteq access for DMDs appropriate to the setting

Question Title

* 5. The role of Blueteq should be evolved to capture common data elements and deliver a more clinically meaningful national database for monitoring and improving clinical outcomes

T